Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
13 February 2024 | Mark S FormanOther Level A | Sell Tax related | 1,638 | $0.97 | $1,588.86 | 48,631 |
13 February 2024 | Kathleen BorthwickCFO | Sell Tax related | 1,470 | $0.97 | $1,425.90 | 28,466 |
2 January 2024 | Edgar B (Chip) CaleCompany Secretary | Sell Tax related | 15,813 | $0.91 | $14,389.83 | 45,995 |
2 January 2024 | Mark S FormanOther Level A | Sell Tax related | 15,813 | $0.91 | $14,389.83 | 45,269 |
2 January 2024 | Kathleen BorthwickCFO | Sell Tax related | 10,672 | $0.91 | $9,711.52 | 25,936 |
28 July 2023 | Simona KingCFO | Sell Tax related | 11,453 | $0.88 | $10,078.64 | 23,994 |
28 June 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 575,195 | $0.84 | $483,163.80 | 8,034,000 |
27 June 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 617,382 | $0.84 | $518,600.88 | 7,458,805 |
16 June 2023 | Alexandros (Alex) FotopoulosCTO | Sell Tax related | 4,052 | $0.93 | $3,778.49 | 28,693 |
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
27 June 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 617,382 | $0.84 | $518,600.88 | 7,458,805 |
28 June 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 575,195 | $0.84 | $483,163.80 | 8,034,000 |
2 January 2024 | Edgar B (Chip) CaleCompany Secretary | Sell Tax related | 15,813 | $0.91 | $14,389.83 | 45,995 |
2 January 2024 | Mark S FormanOther Level A | Sell Tax related | 15,813 | $0.91 | $14,389.83 | 45,269 |
28 July 2023 | Simona KingCFO | Sell Tax related | 11,453 | $0.88 | $10,078.64 | 23,994 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.